Capillary Technologies India Earnings Call Transcripts
Fiscal Year 2027
-
Q2 revenue rose 51% YoY, with adjusted EBITDA margin at 17%; H1 ARR reached INR 1,085 crore. AI-led wins, customer expansion and SessionM drove momentum, while management maintained ~20% organic growth guidance and expects to meet or exceed FY guidance.
-
Q1 revenue grew 43% year-over-year to INR 256 crore, with EBITDA up 132% and normalized PAT at INR 25 crore after adjusting for a one-time cyber fraud loss. SessionM acquisition added $32 million ARR and turned profitable, while AI-led products like aiRA are gaining traction and expected to contribute 5โ10% of revenue this year.
Fiscal Year 2026
-
Revenue grew 23% year-on-year to INR 734 crore in FY 2026, with adjusted EBITDA up 43% and strong cash generation. The SessionM acquisition boosts ARR and Fortune 500 client base, while AI-driven products are gaining traction. Margin expansion may moderate short-term due to integration.